| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/25/2002 | US20020099025 Treatment of neurological disorders |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020099017 Gene designated EXP189 encoding an intercellular adhesion molecule; protein encoded by EXP189 used for diagnostic screening, for treating respiratory and inflammatory disorders, and for detecting genetic abnormalities |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099015 Gene expression control DNA element and associated protein |
| 07/25/2002 | US20020099014 Method for treatment of insulin resistance in obesity and diabetes |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099011 Use of these sequences in the diagnosis, treatment, and prevention of neurological, endocrine, immunological and cell proliferative disorders. |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020099009 Also diagnosing or detecting apoptosis as well as antibodies directed against the protein. |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020098998 P27 prevents cellular migration |
| 07/25/2002 | US20020098585 Hypoxia-mediated neurogenesis |
| 07/25/2002 | US20020098583 Composition for use in the treatment of cell cycle defects, autoimmune diseases, aging, cancer, leukemia and psoriasis |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098578 Synthesis of human procollagens and collagens in recombinant dna systems |
| 07/25/2002 | US20020098576 Recombinant sendai virus |
| 07/25/2002 | US20020098573 Generating preferential vector nucleotide sequences; obtain nucleotide sequences, incubate with preferential exogenous nucleotide sequences, ligate, recover nucleotide sequences |
| 07/25/2002 | US20020098572 Conditional replication and expression system |
| 07/25/2002 | US20020098569 Proteins associated with cell proliferation |
| 07/25/2002 | US20020098568 Zcys7: a member of the cystatin superfamily |
| 07/25/2002 | US20020098566 Human nucleolin-like protein |
| 07/25/2002 | US20020098561 Polypeptide for use in the treatment of thrombosis and arteriosclerosis |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098551 From a hybrid cell formed from the fusion of two or more cells, each of which cell is engineered to express one component of the multimeric protein, as well as a method for screening for successful fusion of the cells |
| 07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
| 07/25/2002 | US20020098549 Mouse EDG1 |
| 07/25/2002 | US20020098548 Nucleotide sequences coding binding protein; for use in evaluating and treating nervous system disorders |
| 07/25/2002 | US20020098546 Canine TAg1 proteins, nucleic acid molecules, and uses thereof |
| 07/25/2002 | US20020098545 Nucleotide sequences coding preferential polypeptide for use in diagnosis, detection and treatment of immunological defects |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098543 Prostate associated Ets protein |
| 07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
| 07/25/2002 | US20020098541 TNFR related gene 12 |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098539 Histamine receptor |
| 07/25/2002 | US20020098538 7TM receptor (AXOR23) |
| 07/25/2002 | US20020098537 Having inhibitory activity on the protease activity of hepatocyte growth factor activator |
| 07/25/2002 | US20020098530 Tumor suppressor gene |
| 07/25/2002 | US20020098525 Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
| 07/25/2002 | US20020098524 Screening peptide library for preferential proteins; obtain library, incubate with antitarget, separate unbound peptides, incubate unbound peptides with target binding protein, detect bound peptide complexes |
| 07/25/2002 | US20020098522 RIP: novel human protein involved in tumor necrosis factor signal transduction |
| 07/25/2002 | US20020098520 Diagnosing preferential nervous system disorders; obtain protein sample, monitor g protein activity, adjustment in activity suggest nervous system disorder |
| 07/25/2002 | US20020098516 Diagnosing preferential genetic disorder in humans; obtain sample, incubate with antibody, detect bound antibody, compare to control, evaluate pattern for genetic disorder |
| 07/25/2002 | US20020098515 Antibody for use in the treatment of cancers and leukemias |
| 07/25/2002 | US20020098514 Polypeptide complex for use in the treatment and diagnosis of non-insulin dependent diabetes mellitus and alzheimer's disease |
| 07/25/2002 | US20020098513 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| 07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
| 07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
| 07/25/2002 | US20020098491 Nuclelotide sequences coding preferential polypeptide; for use in human therapeutics, diagnostics and pharmacology |
| 07/25/2002 | US20020098489 Determining risk of spontaneous abortion in human; obtain cell sample, monitor activity of preferential gene, compare to control, reduced gene expression indicates potential for pregnancy loss |
| 07/25/2002 | US20020098488 Diagnosing mammary gland cancer; obtain tissue sample, extract nucleotide sequences, monitor sequence for mutation, presence of mutation indicates potential for development of mammary gland cancer |
| 07/25/2002 | US20020098480 Nucleic acid mutation detection in histologic tissue |
| 07/25/2002 | US20020098473 Screening for modulators of neurotransmission; obtain cells, monitor expression from glutamate transport protein, incubate with modulator, monitor cells for adjustment in glutamate transmission |
| 07/25/2002 | US20020098277 Proteins are reduced with thiol redox proteins and further reacted with cystamine or oxidized glutathione to prevent reoxidation |
| 07/25/2002 | US20020098236 Transport vectors |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098202 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098200 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 07/25/2002 | US20020098197 Hla binding peptides and their uses |
| 07/25/2002 | US20020098196 Pseudomonas treatment composition and method |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
| 07/25/2002 | US20020098191 Expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer |
| 07/25/2002 | US20020098187 Vascular endothelial cell growth factor antagonists |
| 07/25/2002 | US20020098184 Comprising T-cell dependant antigen, or part thereof, and associated adjuvant which is adapted to stimulate T-cell lymphocyte via cell surface receptor CD28 |
| 07/25/2002 | US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it |
| 07/25/2002 | US20020098170 Herpes simplex virus type 1 ( HSV-1)-derived vector for selectively inhibiting maligant cells and methods for its use to treat cancer and to express desired traits in maligant and non-miligant mammalian cells |
| 07/25/2002 | US20020098169 Novel sequences and their use |
| 07/25/2002 | US20020098163 Isolated nucleic acid molecules used for immunotherapy |
| 07/25/2002 | DE10104094C1 Increasing viral replication and yield in cell cultures, useful e.g. for detecting residual hepatitis A in inactivated products, by blocking activation of RNaseL |
| 07/25/2002 | DE10055545A1 Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen For expression in eukaryotes optimized HPV 16 L1 and HPV 16 L2 coding DNA sequences |
| 07/25/2002 | CA2771117A1 Bacillus thuringiensis insecticidal proteins |
| 07/25/2002 | CA2450929A1 Vegfr-3 binding peptides and their use for inhibiting angiogenesis |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2440317A1 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | CA2435394A1 Modified zinc finger binding proteins |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2435054A1 Chlamydia heat shock protein |
| 07/25/2002 | CA2435037A1 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | CA2434928A1 Genes |
| 07/25/2002 | CA2434802A1 Isolating cells expressing secreted proteins |
| 07/25/2002 | CA2434696A1 P27 prevents cellular migration |
| 07/25/2002 | CA2434490A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | CA2434472A1 Gelling vegetable protein |
| 07/25/2002 | CA2434364A1 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/25/2002 | CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433802A1 Secretory molecules |
| 07/25/2002 | CA2433650A1 Gene disrupted yeast |
| 07/25/2002 | CA2433394A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/25/2002 | CA2433354A1 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432882A1 Regulators of fungal gene expression |
| 07/25/2002 | CA2432800A1 Regulated activation of cell-membrane receptors by metal-chelating agonists |